Cibus, Inc. (NASDAQ:CBUS), an agricultural technology company, has welcomed the European Commission's proposal on the regulation of plants obtained from New Genomic Techniques (NGTs). The proposal aims to adapt EU legislation to scientific and technological progress, enabling NGTs to contribute to sustainable agriculture, climate resilience, and food security. The proposed regulation identifies a 'Conventional-like' category of NGT products that would be regulated as conventional varieties. Products from Cibus' gene editing platform, such as canola and oilseed rape resistant to disease or with reduced seed losses, would be considered 'Conventional-like'.